RLP CHOLESTEROL IMMUNOSEPARATION ASSAY— 510(k) K991083

Substantially Equivalent

Otsuka Pharmaceutical Co., Ltd.

FDA 510(k) clearance K991083 for RLP CHOLESTEROL IMMUNOSEPARATION ASSAY, Substantially Equivalent on 1999-08-20. Applicant: Otsuka Pharmaceutical Co., Ltd..

Clearance details

Applicant: Otsuka Pharmaceutical Co., Ltd.
Product code: Code CHH
Advisory panel: Clinical Chemistry
Date received: 1999-03-31
Decision date: 1999-08-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rockville, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.